Adial Pharmaceuticals awarded new U.S. patent on genotype-specific treatment
PremiumThe FlyAdial Pharmaceuticals awarded new U.S. patent on genotype-specific treatment
2M ago
Adial Pharmaceuticals announce clinical study results from AD04-103 study
Premium
The Fly
Adial Pharmaceuticals announce clinical study results from AD04-103 study
2M ago
Adial Pharmaceuticals Focuses on Strategic Growth Initiatives
Premium
Company Announcements
Adial Pharmaceuticals Focuses on Strategic Growth Initiatives
3M ago
Adial granted U.S. patent for treatment of alcohol, drug dependence
PremiumThe FlyAdial granted U.S. patent for treatment of alcohol, drug dependence
4M ago
Adial Pharmaceuticals Advances AD04 with Promising Study Results
Premium
Company Announcements
Adial Pharmaceuticals Advances AD04 with Promising Study Results
5M ago
Adial Pharmaceuticals announces topline results from AD04-103 PK study
Premium
The Fly
Adial Pharmaceuticals announces topline results from AD04-103 PK study
5M ago
Adial Pharmaceuticals appoints Shah as Chief Financial Officer
PremiumThe FlyAdial Pharmaceuticals appoints Shah as Chief Financial Officer
5M ago
Adial receives notice of allowance for U.S. patent related to AD04
Premium
The Fly
Adial receives notice of allowance for U.S. patent related to AD04
6M ago
Adial Pharmaceuticals commends NIAAA’s new definition of recovery
Premium
The Fly
Adial Pharmaceuticals commends NIAAA’s new definition of recovery
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100